全文获取类型
收费全文 | 923篇 |
免费 | 0篇 |
专业分类
电工技术 | 1篇 |
化学工业 | 2篇 |
建筑科学 | 1篇 |
轻工业 | 2篇 |
无线电 | 1篇 |
一般工业技术 | 26篇 |
冶金工业 | 886篇 |
原子能技术 | 2篇 |
自动化技术 | 2篇 |
出版年
2012年 | 1篇 |
2009年 | 1篇 |
2004年 | 1篇 |
2003年 | 1篇 |
2000年 | 1篇 |
1999年 | 26篇 |
1998年 | 244篇 |
1997年 | 145篇 |
1996年 | 101篇 |
1995年 | 55篇 |
1994年 | 45篇 |
1993年 | 50篇 |
1992年 | 6篇 |
1991年 | 11篇 |
1990年 | 17篇 |
1989年 | 11篇 |
1988年 | 14篇 |
1987年 | 15篇 |
1986年 | 11篇 |
1985年 | 13篇 |
1983年 | 5篇 |
1982年 | 4篇 |
1981年 | 11篇 |
1980年 | 12篇 |
1979年 | 1篇 |
1978年 | 6篇 |
1977年 | 25篇 |
1976年 | 64篇 |
1975年 | 2篇 |
1974年 | 3篇 |
1973年 | 3篇 |
1972年 | 4篇 |
1970年 | 2篇 |
1969年 | 1篇 |
1968年 | 4篇 |
1966年 | 2篇 |
1965年 | 1篇 |
1962年 | 2篇 |
1955年 | 1篇 |
1954年 | 1篇 |
排序方式: 共有923条查询结果,搜索用时 15 毫秒
1.
2.
Hepatitis C, which is caused by the hepatitis C virus (HCV), is a major public health problem in the United States. HCV is most efficiently transmitted through large or repeated percutaneous exposures to blood. Most patients with acute HCV infection develop persistent infection, and 70 percent of patients develop chronic hepatitis. HCV-associated chronic liver disease results in 8,000 to 10,000 deaths per year, and the annual costs of acute and chronic hepatitis C exceed $600 million. An estimated 3.9 million Americans are currently infected with HCV, but most of these persons are asymptomatic and do not know they are infected. To identify them, primary health care professionals should obtain a history of high-risk practices associated with the transmission of HCV and other bloodborne pathogens from all patients. Routine testing is currently recommended only in patients who are most likely to be infected with HCV. 相似文献
3.
OBJECTIVE: To propose a definition for stage IA1 cervical adenocarcinoma, based on the International Federation of Gynecology and Obstetrics (FIGO) staging system, and to determine if patients meeting criteria might be candidates for conservative surgery. METHODS: Two hundred women were diagnosed with early-stage cervical adenocarcinoma from 1982 to 1996. Histopathologic sections were reviewed by a gynecologic pathologist. Medical records were reviewed, and patients included in this study had microscopically identifiable lesions, up to 3 mm invasive depth, up to 7 mm tumor width, and negative margins if cone biopsy was performed. RESULTS: Twenty-one patients with microinvasive adenocarcinoma met criteria for FIGO stage IA1 carcinoma of the cervix. The median (range) follow-up was 76 (30-172) months and median (range) patient age was 38 (24-75) years. Definitive treatment included type II or III radical hysterectomy in 16 cases, simple abdominal or vaginal hysterectomy in four cases, and loop electrosurgical excision procedure in one case; one patient received adjuvant pelvic radiation. The histologic subtypes were endocervical adenocarcinoma in 18 cases, adenosquamous carcinoma in two cases, and clear-cell adenocarcinoma in one case. There was no evidence of parametrial invasion or lymph node metastases in any patient who had radical surgery, and there were no disease recurrences. CONCLUSION: Patients with microinvasive adenocarcinoma who met criteria for FIGO stage IA1 cervical carcinoma had disease limited to the cervix, and conservative surgery, such as cone biopsy or simple hysterectomy, might offer them definitive treatment. 相似文献
4.
5.
6.
7.
8.
9.
SA Gould EE Moore FA Moore JB Haenel JM Burch H Sehgal L Sehgal R DeWoskin GS Moss 《Canadian Metallurgical Quarterly》1997,43(2):325-31; discussion 331-2
We have previously documented the safety of 1 unit (50 gram) of human polymerized hemoglobin (Poly SFH-P) in healthy volunteers. This report describes the first patient trial to assess the therapeutic benefit of Poly SFH-P in acute blood loss. Thirty-nine patients received 1 (n = 14), 2 (n = 2), 3 (n = 15), or 6 (n = 8) units of Poly SFH-P instead of red cells as part of their blood replacement after trauma and urgent surgery. There were no safety issues related to the infusion of Poly SFH-P. The plasma hemoglobin concentration ([Hb]) after the infusion of 6 units (300 gram) of Poly SFH-P was 4.8 +/- 0.8 g/dL (mean +/- SD). Although the red cell [Hb] fell to 2.9 +/- 1.2 g/dL, the total [Hb] was maintained at 7.5 +/- 1.2 g/dL. Poly SFH-P maintained total [Hb], despite the marked fall in red cell [Hb] due to blood loss. The utilization of O2 (extraction ratio) was 27 +/- 16% from the red cells and 37 +/- 13% from the Poly SFH-P. Twenty-three patients (59%) avoided allogeneic transfusions during the first 24 hours after blood loss. Poly SFH-P effectively loads and unloads O2 and maintains total hemoglobin in lieu of red cells after acute blood loss, thereby reducing allogeneic transfusions. Poly SFH-P seems to be a clinically useful blood substitute. 相似文献
10.
Effects of insertions and deletions in a beta-bulge region of Escherichia coli dihydrofolate reductase 总被引:1,自引:0,他引:1
The role of a beta-bulge in Escherichia coli dihydrofolate reductase (DHFR)
has been explored by a series of insertion and deletion mutations.
Insertion of a seven amino acid sequence from a structurally equivalent
'beta-blowout' sequence from human DHFR destabilizes E. coli DHFR by 3.6
kcal/mol and decreases catalytic efficiency (kcat/K(m)) 34- fold. Deletion
of F137, delta 137, the looped out residue in the bulge, also destabilizes
E. coli DHFR by 2.8 kcal/mol but only decreases catalytic efficiency
threefold. Concurrent deletion of F137 and mutation of, V136 to proline to
try and maintain the strand twist associated with the beta-bulge decreases
protein stability by 3.4 kcal/mol and decreases catalytic efficiency
84-fold. These insertion/deletion mutations were also constructed in a D27S
DHFR background. The D27S mutation has been described previously and
proposed to remove the catalytic acid from the active site. The delta 137
mutation partially suppresses the effect of the D27S mutation as it
decreases the K(m) for substrate, dihydrofolate, twofold. Non-additive
effects are observed for the insertion/deletion mutations in wild-type
versus D27S DHFR backgrounds, consistent with structural changes.
相似文献